Medication costs for diabetes patients constituted 43% of the total direct medical burden in the US in 2017 comprising $15 billion for insulin, $15.9 billion for other antidiabetic agents, and $71.2 billion in excess use of other prescription medications [104]. Here, INS is linked to diabetes mellitus.